Data as-of 2026-07-06 close. Pre-computed summary JSONs across all 79 price-bearing watchlists (978 unique tickers). Numbers read directly from JSON — no prose math. Prior scan: 2026-06-26-monster-scan (191 monsters).

MONSTER criteria: trend = "strong-up" AND goldenCross = true AND vsSma200 > 30, sorted by vsSma200 desc.

Breadth keeps compressing: 161 monsters today versus 191 a scan ago and a 299-name peak on 2026-05-29 — the fourth straight narrowing print. The names that remain qualified are concentrated in two clusters: biotech-capital-cycle names running hot off pipeline catalysts (ABSI +76% 30D at RSI 73, MRNA +72% 30D at RSI 82, APGE +61% 30D at RSI 82), and the memory/optical/semis complex that has owned this board for months (SNDK, MU, WDC, STX, MXL, IBIDF, ALAB, SIMO — all still 90-175% above their 200-day). The most important structural read isn't in the monster list at all: NVDA and AVGO have both trend-flipped to weak-down, sitting at just +2.3% and +3.8% vs SMA200 respectively — a full step down from the prior scan's "barely holding above SMA200, RSI 38-40" secular-pullback framing. Golden cross technically still holds on both, but calling them "re-entry watch" is now generous. SOXL is the sharper warning — the 3x leveraged semis ETF is still sitting at +121.5% above its 200-day (would rank top-10 if trend qualified) but trend flipped weak-down, meaning short-term momentum broke while the long-run extension hasn't unwound at all. That combination — extended but no longer trending up — is the textbook shape of distribution, not accumulation.

Tag key: ⚠️OB = RSI ≥ 70 (overbought); 🔥 = >50% above VWAP (parabolic vs. average buyer); ⚡ = leveraged ETF (decay risk); (early) = RSI < 50; CONF = RSI 50-69 (confirmed trend, not yet overbought).

(161 names total; the remaining 106 sit at +30-65% vs SMA200 and include OKTA, CRWD, DDOG, GLW, LRCX, KLAC, ONTO, ASML, TSM, IBKR, CAT, AAL, DAL, CSCO, TXN, SMH, SOXX, TQQQ ⚡, TECL ⚡, TNA ⚡, EDIT, NTLA, ARWR, ILMN, KYMR, MOG-A, GEV — omitted for length.)

Leveraged ETF note: LABU (3x biotech, RSI 78, +88% vs SMA200) is the only leveraged name still clearing the RSI≥70 overbought bar. TECL, TNA, and TQQQ are in the broader monster list at lower RSI (48-59) but carry the same decay risk on any new position — treat as a heat signal, not an entry.

The guard (RSI > 92 AND a single-day gap > +100%) caught zero names in this run. The prior scan's flagged artifact, DD (DuPont), has normalized: RSI is back to 50.7, vs SMA200 +10%, change1d ~0% — it no longer meets any monster or suspect criterion and has fallen off the board entirely. Treat that as resolved, not as evidence the guard is loose — it's the guard doing its job.

• Monster count: 191 → 161. Fourth straight narrowing print (299 peak 05-29 → 225 → 205 → 191 → 161).
• NVDA and AVGO trend-flipped to weak-down. Both were "secular pullback, RSI 38-40, barely above SMA200" last scan. Now they've lost the uptrend classification outright (NVDA vs SMA200 +2.3% RSI 42.3; AVGO +3.8% RSI 45.2). Golden cross intact on both, but the trend label is a real step down.
• SOXL (3x semis) trend-flipped to weak-down while still +121.5% above SMA200. This is the sharpest signal on the board this scan: a leveraged proxy for the whole semis complex that stayed massively extended on price but lost its short-term uptrend — extension without momentum is the distribution pattern, not a buyable pullback.
• DD (DuPont) data artifact resolved. RSI 88→50.7, no longer a monster or a suspect.
• RSI mix improved slightly — 39 overbought names vs 45 last scan, even as the total count shrank, meaning the shrinkage is coming disproportionately from mid-tier names falling out, not just overbought names cooling off.
• Biotech-capital-cycle stayed the hottest live cluster — ABSI, MRNA, APGE, TXG, TWST, RVMD all cluster in the top 25 with 30D moves of +28% to +76%, several already RSI 70+.